Literature DB >> 20460084

Spotlight on measles 2010: An epidemiological overview of measles outbreaks in Poland in relation to the measles elimination goal.

J Rogalska1, S Santibanez, A Mankertz, A Makowka, L Szenborn, P Stefanoff.   

Abstract

The objective of this study was to describe transmission chains of measles observed in Poland during 2008-2009. A decade ago, the incidence of measles in Poland declined and approached one case per million inhabitants one of the World Health Organization's criteria for measles elimination. Following a period of very few reported measles cases (2003 to 2005), an increase in incidence was observed in 2006. Since then, the incidence has constantly exceeded one case per million inhabitants. Of 214 measles cases reported in 2008 and 2009 in Poland, 164 (77%) were linked to 19 distinct outbreaks, with 79% of cases belonging to the Roma ethnic group. Outbreaks in the non-Roma Polish population had different dynamics compared to those in the Roma population. On average, measles outbreaks in Roma communities involved 10 individuals, seven of whom were unvaccinated, while outbreaks in the non-Roma Polish population involved five individuals, half of whom were incompletely vaccinated. The majority of outbreaks in Roma communities were related to importation of virus from the United Kingdom. In six outbreaks, the epidemiologic investigation was confirmed by identification of genotype D4 closely related to measles viruses detected in the United Kingdom and Germany. Our data indicate that Poland is approaching measles elimination, but measles virus circulation is still sustained in a vulnerable population. More efforts are needed to integrate the Roma ethnic group into the Polish healthcare system and innovative measures to reach vulnerable groups should be explored.

Entities:  

Mesh:

Year:  2010        PMID: 20460084     DOI: 10.2807/ese.15.17.19549-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  6 in total

1.  Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent.

Authors:  Camille Lévy; Fouzia Amirache; Anais Girard-Gagnepain; Cecilia Frecha; Francisco J Roman-Rodríguez; Ornellie Bernadin; Caroline Costa; Didier Nègre; Alejandra Gutierrez-Guerrero; Lenard S Vranckx; Isabelle Clerc; Naomi Taylor; Lars Thielecke; Kerstin Cornils; Juan A Bueren; Paula Rio; Rik Gijsbers; François-Loïc Cosset; Els Verhoeyen
Journal:  Blood Adv       Date:  2017-10-24

2.  Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.

Authors:  Cecilia Frecha; Camille Lévy; Caroline Costa; Didier Nègre; Fouzia Amirache; Robin Buckland; Steven J Russell; François-Loïc Cosset; Els Verhoeyen
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

3.  Spread of measles virus D4-Hamburg, Europe, 2008-2011.

Authors:  Annette Mankertz; Zefira Mihneva; Hermann Gold; Sigrid Baumgarte; Armin Baillot; Rudolph Helble; Hedwig Roggendorf; Golubinka Bosevska; Jasminka Nedeljkovic; Agata Makowka; Veronik Hutse; Heidemarie Holzmann; Stefan W Aberle; Samuel Cordey; Gheorghe Necula; Andreas Mentis; Gulay Korukluoğlu; Michael Carr; Kevin E Brown; Judith M Hübschen; Claude P Muller; Mick N Mulders; Sabine Santibanez
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

4.  Preliminary findings indicate nosocomial transmission and Roma population as most affected group in ongoing measles B3 genotype outbreak in Bulgaria, March to August 2017.

Authors:  Anna Kurchatova; Stefka Krumova; Nadezhda Vladimirova; Lubomira Nikolaeva-Glomb; Asya Stoyanova; Todor Kantardjiev; Nina Gatcheva
Journal:  Euro Surveill       Date:  2017-09-07

Review 5.  Adverse events of vaccines and the consequences of non-vaccination: a critical review.

Authors:  Luana Raposo de Melo Moraes Aps; Marco Aurélio Floriano Piantola; Sara Araujo Pereira; Julia Tavares de Castro; Fernanda Ayane de Oliveira Santos; Luís Carlos de Souza Ferreira
Journal:  Rev Saude Publica       Date:  2018-04-12       Impact factor: 2.106

6.  20 years of communicating facts and figures.

Authors:  Ines Steffens
Journal:  Euro Surveill       Date:  2016-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.